PF-Atlas › Clinical Trials › NCT03559166

First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

BLD-2660 · Phase 1

Registry ID

NCT03559166

Phase

Phase 1

Status

Completed

Drug / intervention

BLD-2660

Sponsor

Blade Therapeutics

Start

2018-07-11

Enrollment

Locations

About this trial

First in Human single ascending dose followed by multiple ascending doses in healthy volunteers.

View NCT03559166 on ClinicalTrials.gov →

Explore related

All BLD-2660 trials All IPF trials

Related trials

BLD-2660 — NCT04244825

Medical disclaimer. This page summarizes public trial data for NCT03559166 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.